Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward

Affiliations

¹ University of Birmingham Microbiome Treatment Centre, Birmingham B15 2TT, UK; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
² University of Birmingham Microbiome Treatment Centre, Birmingham B15 2TT, UK; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Electronic address: m.n.quraishi@bham.ac.uk.
³ University of Birmingham Microbiome Treatment Centre, Birmingham B15 2TT, UK.
⁴ University of Birmingham Microbiome Treatment Centre, Birmingham B15 2TT, UK; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
⁵ Department of Paediatric Gastroenterology, Royal Hospital for Children Glasgow, Glasgow, UK.
⁶ Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, UK.
⁷ Department of Gastroenterology, St Marks Hospital, London, UK.
⁸ Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.

Comment

Christopher A Green et al. Lancet Gastroenterol Hepatol. 2020 Jun.

. 2020 Jun;5(6):531.

doi: 10.1016/S2468-1253(20)30089-3. Epub 2020 Mar 30.

¹ University of Birmingham Microbiome Treatment Centre, Birmingham B15 2TT, UK; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
² University of Birmingham Microbiome Treatment Centre, Birmingham B15 2TT, UK; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Electronic address: m.n.quraishi@bham.ac.uk.
³ University of Birmingham Microbiome Treatment Centre, Birmingham B15 2TT, UK.
⁴ University of Birmingham Microbiome Treatment Centre, Birmingham B15 2TT, UK; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
⁵ Department of Paediatric Gastroenterology, Royal Hospital for Children Glasgow, Glasgow, UK.
⁶ Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, UK.
⁷ Department of Gastroenterology, St Marks Hospital, London, UK.
⁸ Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.

No abstract available

Comment on

Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel.
Ianiro G, Mullish BH, Kelly CR, Sokol H, Kassam Z, Ng SC, Fischer M, Allegretti JR, Masucci L, Zhang F, Keller J, Sanguinetti M, Costello SP, Tilg H, Gasbarrini A, Cammarota G. Ianiro G, et al. Lancet Gastroenterol Hepatol. 2020 May;5(5):430-432. doi: 10.1016/S2468-1253(20)30082-0. Epub 2020 Mar 17. Lancet Gastroenterol Hepatol. 2020. PMID: 32192627 Free PMC article. No abstract available.

1. Ianiro G, Mullish BH, Kelly CR. Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel. Lancet Gastroenterol Hepatol. 2020 doi: 10.1016/S2468-1253(20)30082-0. published online March 17. - DOI - PMC - PubMed
1. European Centre for Disease Prevention and Control Situation update for the EU/EEA and the UK, as of 19 March 2020. March 19, 2020. https://www.ecdc.europa.eu/en/cases-2019-ncov-eueea
1. Xu Y, Li X, Zhu B. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020 doi: 10.1038/s41591-020-0817-4. published online March 13. - DOI - PMC - PubMed
1. Bai Y, Yao L, Wei T. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020 doi: 10.1001/jama.2020.2565. published online Feb 21. - DOI - PMC - PubMed
1. US Food and Drug Administration Fecal microbiota for transplantation: safety alert – risk of serious adverse events likely due to transmission of pathogenic organisms. March 12, 2020. https://www.fda.gov/safety/medical-product-safety-information/fecal-micr...